Ethical Considerations for Clinical Investigations of Medical Products Involving Children: Draft Guidance for Industry, Sponsors, and IRBs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 26, 2022
April 12, 2024
e95b55bc-b376-4b9d-a28e-612d442be498
Related Documents
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
Psychedelic Drugs: Considerations for Clinical Investigations
Guidance DocumentJune 23, 2023Center for Drug Evaluation and Research
General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products
Guidance DocumentSeptember 7, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.